ArticleJournal of medicinal chemistry2025

Correction to "Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema".

Rebecca L Davie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.